CompletedNot Applicable

Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations

France45 participantsStarted 2012-10-11

Plain-language summary

The aim of this study is to identify genetic abnormalities and molecular pathways associated with the occurrence of CCAM.

Who can participate

Age range8 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children \< 8 years * Thoracic surgery for congenital lung malformation * Parental written consent Exclusion Criteria: * Children \> 8 years * Previous infection of the malformation * Parental rebutal

What they're measuring

mRNA expression

Timeframe: at Day 0

Trial details

NCT IDNCT01732185

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-10-11

View on ClinicalTrials.gov More Congenital Cystic Adenomatoid Malformation (CCAM) trials